4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-002468
Director bought 423 shares at an average $4.56 ($1,930)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jones James Director | 2021-12-01 | Purchase | +21 | $4.14 | $87 | 18,963 | D |
| Jones James Director | 2021-12-02 | Purchase | +21 | $3.84 | $81 | 18,984 | D |
| Jones James Director | 2021-12-03 | Purchase | +21 | $4.47 | $94 | 19,005 | D |
| Jones James Director | 2021-12-06 | Purchase | +21 | $4.46 | $94 | 19,026 | D |
| Jones James Director | 2021-12-07 | Purchase | +21 | $5.61 | $118 | 19,047 | D |
| Jones James Director | 2021-12-08 | Purchase | +21 | $6.15 | $129 | 19,068 | D |
| Jones James Director | 2021-12-09 | Purchase | +21 | $5.81 | $122 | 19,089 | D |
| Jones James Director | 2021-12-10 | Purchase | +21 | $4.82 | $101 | 19,110 | D |
| Jones James Director | 2021-12-13 | Purchase | +30 | $4.36 | $131 | 19,140 | D |
| Jones James Director | 2021-12-14 | Purchase | +30 | $4.28 | $128 | 19,170 | D |
| Jones James Director | 2021-12-15 | Purchase | +30 | $4.29 | $129 | 19,200 | D |
| Jones James Director | 2021-12-16 | Purchase | +50 | $4.53 | $227 | 19,250 | D |
| Jones James Director | 2021-12-17 | Purchase | +50 | $4.17 | $209 | 19,300 | D |
| Jones James Director | 2021-12-20 | Purchase | +65 | $4.33 | $281 | 19,365 | D |
| Open-market purchases · 423 sh · avg $4.56 · $1,930 | |||||||
Loading xslF345X03/doc4.xml…